FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303672008> ?p ?o ?g. }

• W4303672008 abstract "Bariatric surgery has adverse effects on the muscular-skeletal system with loss of bone mass and muscle mass and an increase in the risk of fracture. Zoledronic acid is widely used in osteoporosis and prevents bone loss and fracture. Bisphosphonates may also have positive effects on skeletal muscle. The aim of this study is to investigate the effects of zoledronic acid for the prevention of bone and muscle loss after bariatric surgery. METHODS/DESIGN: This is a randomized double-blind placebo-controlled study. Sixty women and men with obesity aged 35 years or older will complete baseline assessments before randomization to either zoledronic acid (5 mg in 100 ml isotonic saline) or placebo (100 ml isotonic saline only) 3 weeks before surgery with Roux-en-Y-gastric bypass (RYGB) or sleeve gastrectomy (SG). Follow-up assessments are performed 12 and 24 months after surgery. The primary outcome is changes in lumbar spine volumetric bone mineral density (vBMD) assessed by quantitative computed tomography (QCT). Secondary bone outcomes are changes in proximal femur vBMD assessed by QCT. Changes in cortical and trabecular bone microarchitecture and estimated bone strength will be assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT). Cortical material bone strength at the mid-tibia diaphysis will be assessed using microindentation and fasting blood samples will be obtained to assess biochemical markers of bone turnover and calcium metabolism. Secondary muscle outcomes include whole body lean mass assessed using dual-energy X-ray absorptiometry. Dynamometers will be used to assess handgrip, shoulder, ankle, and knee muscle strength. Short Physical Performance Battery, 7.6-m walking tests, 2-min walking test, and a stair climb test will be assessed as biomarkers of physical function. Self-reported physical activity level is assessed using International Physical Activity Questionnaire (IPAQ).Results from this study will be instrumental for the evidence-based care of patients undergoing bariatric surgery.ClinicalTrials.gov NCT04742010. Registered on 5 February 2021." @default.
• W4303672008 created "2022-10-08" @default.
• W4303672008 creator A5029187587 @default.
• W4303672008 creator A5046323767 @default.
• W4303672008 creator A5058914154 @default.
• W4303672008 creator A5061853414 @default.
• W4303672008 creator A5078027857 @default.
• W4303672008 date "2022-10-08" @default.
• W4303672008 modified "2023-10-01" @default.
• W4303672008 title "Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial" @default.
• W4303672008 cites W1604096291 @default.
• W4303672008 cites W1607536434 @default.
• W4303672008 cites W1821799397 @default.
• W4303672008 cites W1946529897 @default.
• W4303672008 cites W1963714242 @default.
• W4303672008 cites W1973498853 @default.
• W4303672008 cites W1993035292 @default.
• W4303672008 cites W1996104146 @default.
• W4303672008 cites W2014973716 @default.
• W4303672008 cites W2016253728 @default.
• W4303672008 cites W2044026928 @default.
• W4303672008 cites W2066056548 @default.
• W4303672008 cites W2072120617 @default.
• W4303672008 cites W2079397680 @default.
• W4303672008 cites W2093274439 @default.
• W4303672008 cites W2101752728 @default.
• W4303672008 cites W2123816368 @default.
• W4303672008 cites W2145051081 @default.
• W4303672008 cites W2151845115 @default.
• W4303672008 cites W2161744940 @default.
• W4303672008 cites W2163710303 @default.
• W4303672008 cites W2166023752 @default.
• W4303672008 cites W2184711170 @default.
• W4303672008 cites W2327500873 @default.
• W4303672008 cites W2481141343 @default.
• W4303672008 cites W2491708948 @default.
• W4303672008 cites W2542199058 @default.
• W4303672008 cites W2552102528 @default.
• W4303672008 cites W2592071604 @default.
• W4303672008 cites W2592483099 @default.
• W4303672008 cites W2594255156 @default.
• W4303672008 cites W2595498215 @default.
• W4303672008 cites W2775551194 @default.
• W4303672008 cites W2782814312 @default.
• W4303672008 cites W2794997744 @default.
• W4303672008 cites W2807863564 @default.
• W4303672008 cites W2884324039 @default.
• W4303672008 cites W2892300062 @default.
• W4303672008 cites W2893745569 @default.
• W4303672008 cites W2898108906 @default.
• W4303672008 cites W3014677392 @default.
• W4303672008 cites W3080081028 @default.
• W4303672008 cites W3083242037 @default.
• W4303672008 cites W3120839777 @default.
• W4303672008 cites W3133628232 @default.
• W4303672008 cites W3160002825 @default.
• W4303672008 doi "https://doi.org/10.1186/s13063-022-06766-z" @default.
• W4303672008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36209245" @default.
• W4303672008 hasPublicationYear "2022" @default.
• W4303672008 type Work @default.
• W4303672008 citedByCount "0" @default.
• W4303672008 crossrefType "journal-article" @default.
• W4303672008 hasAuthorship W4303672008A5029187587 @default.
• W4303672008 hasAuthorship W4303672008A5046323767 @default.
• W4303672008 hasAuthorship W4303672008A5058914154 @default.
• W4303672008 hasAuthorship W4303672008A5061853414 @default.
• W4303672008 hasAuthorship W4303672008A5078027857 @default.
• W4303672008 hasBestOaLocation W43036720081 @default.
• W4303672008 hasConcept C126322002 @default.
• W4303672008 hasConcept C126894567 @default.
• W4303672008 hasConcept C141071460 @default.
• W4303672008 hasConcept C2776326535 @default.
• W4303672008 hasConcept C2776541429 @default.
• W4303672008 hasConcept C2776886416 @default.
• W4303672008 hasConcept C2777425516 @default.
• W4303672008 hasConcept C71924100 @default.
• W4303672008 hasConceptScore W4303672008C126322002 @default.
• W4303672008 hasConceptScore W4303672008C126894567 @default.
• W4303672008 hasConceptScore W4303672008C141071460 @default.
• W4303672008 hasConceptScore W4303672008C2776326535 @default.
• W4303672008 hasConceptScore W4303672008C2776541429 @default.
• W4303672008 hasConceptScore W4303672008C2776886416 @default.
• W4303672008 hasConceptScore W4303672008C2777425516 @default.
• W4303672008 hasConceptScore W4303672008C71924100 @default.
• W4303672008 hasIssue "1" @default.
• W4303672008 hasLocation W43036720081 @default.
• W4303672008 hasLocation W43036720082 @default.
• W4303672008 hasLocation W43036720083 @default.
• W4303672008 hasLocation W43036720084 @default.
• W4303672008 hasLocation W43036720085 @default.
• W4303672008 hasLocation W43036720086 @default.
• W4303672008 hasOpenAccess W4303672008 @default.
• W4303672008 hasPrimaryLocation W43036720081 @default.
• W4303672008 hasRelatedWork W2051948937 @default.
• W4303672008 hasRelatedWork W2092013139 @default.
• W4303672008 hasRelatedWork W2093936017 @default.
• W4303672008 hasRelatedWork W2359663220 @default.
• W4303672008 hasRelatedWork W2362701657 @default.
• W4303672008 hasRelatedWork W2394357823 @default.
• W4303672008 hasRelatedWork W2396850148 @default.

• next